Ambys is a California-based biotechnology company that develops and commercializes cell and gene therapies for the treatment of liver diseases.
Business Model:
Revenue: $8.1M
Employees: 51-200
Address: 131 Oyster Point Boulevard
City: South San Francisco
State: CA
Zip: 94080
Country: US
Ambys is a California-based biotechnology company that develops and commercializes cell and gene therapies for the treatment of liver diseases.
Contact Phone:
+16504817660
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2021 | Series A | 6 | $47M |
Alexandria Venture Investments Laurion Capital Management Schroders Capital Smilegate Investment Takeda Third Rock Ventures Alexandria Venture Investments Laurion Capital Management Schroders Capital Smilegate Investment Takeda Third Rock Ventures |
8/2018 | Series A | 2 | $60M |
Takeda Ventures Third Rock Ventures Takeda Ventures Third Rock Ventures |
8/2018 | Series A | $140M |
Third Rock Ventures Takeda Pharmaceutical Co. Ltd |
8/2018 | Corporate Round | 1 | $80M |
Takeda Takeda |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|